(4-Nitrophenyl) Thiazol-5-ylmethyl Carbonate

Product Overview

(4-Nitrophenyl) Thiazol-5-ylmethyl Carbonate is a specialized organic compound designed for advanced pharmaceutical synthesis. This chemical features a reactive carbonate linkage connected to a nitrophenyl group and a thiazole ring, making it an essential building block in the construction of complex molecular structures. Our manufacturing process ensures high consistency and reliability, catering to the rigorous demands of the fine chemical and pharmaceutical industries.

The presence of the 4-nitrophenyl moiety serves as an excellent leaving group, facilitating efficient nucleophilic substitution reactions. This characteristic is particularly valuable when synthesizing active pharmaceutical ingredients where precise stereochemistry and functional group tolerance are required. We produce this intermediate under strict quality control protocols to guarantee batch-to-batch reproducibility.

Physicochemical Properties

Understanding the physical and chemical properties of this compound is vital for process optimization. The substance presents as a light yellow crystalline solid, indicating high structural order and purity. With a molecular formula of C11H8N2O5S and a molecular weight of 280.257 g/mol, it exhibits stable thermal properties suitable for various reaction conditions. The melting point ranges between 126 to 127 degrees Celsius, providing a clear identifier for quality verification.

The density is approximately 1.5 plus or minus 0.1 g/cm3, and the compound demonstrates a high boiling point under standard atmospheric pressure. These properties suggest that the material is stable under normal storage conditions but requires careful handling during high-temperature synthesis steps. The flash point indicates standard safety precautions should be observed during industrial handling to prevent ignition sources.

Industrial Applications

This carbonate derivative is primarily utilized as a key intermediate in the synthesis of protease inhibitors. Specifically, it plays a critical role in the manufacturing pathway of antiretroviral medications. The thiazole ring structure is a common motif in medicinal chemistry, often contributing to the biological activity and metabolic stability of the final drug product. By providing a high-purity precursor, we enable downstream manufacturers to achieve better yields and reduce impurity profiles in their final active pharmaceutical ingredients.

Beyond specific antiviral applications, this building block can be employed in the development of novel heterocyclic compounds. Researchers value the reactivity of the carbonate group for introducing thiazolyl methyl segments into larger molecular scaffolds. Our team supports custom synthesis routes to accommodate specific research and development needs within the pharmaceutical sector.

Quality Specifications

Storage and Handling

To maintain the integrity of the product, proper storage conditions are essential. The material should be kept in a cool, ventilated place away from direct sunlight and moisture. We recommend storing the compound in its original packaging until ready for use to prevent contamination. Standard industrial safety measures apply, including the use of personal protective equipment during handling to avoid skin or eye contact.

Packaging is available in 25 kg drums, ensuring secure transport for bulk orders. We also offer flexible packaging solutions according to customer requirements to fit specific logistics needs. Our global supply chain ensures timely delivery to manufacturing facilities worldwide, supported by comprehensive documentation including Certificates of Analysis and safety data sheets.

Why Choose Our Intermediates

• Consistent high purity levels exceeding 98 percent for reliable synthesis outcomes.
• Robust quality assurance systems with full traceability for every batch produced.
• Competitive bulk pricing structures designed for large-scale industrial manufacturing.
• Dedicated technical support team to assist with application-specific inquiries.
• Compliance with international regulatory standards for pharmaceutical raw materials.